Quidel | QDEL - Ebitda


Quidel reported $148M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Agilent USD 577M 77M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bruker USD 143.2M 33.2M Jun/2026
Charles River Laboratories USD 298.04M 25.1M Sep/2026
Danaher USD 2.1B 257M Sep/2026
Haemonetics USD 111.41M 15.25M Sep/2026
Illumina USD 330M 80M Jun/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Merit Medical Systems USD 103.93M 461K Sep/2026
Mettler Toledo International USD 366.1M 43.45M Sep/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Neogen USD 41.6M 3.8M Jun/2026
OraSure Technologies USD -17.7M 4.06M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quidel USD 148M 18.7M Sep/2026
Revvity USD 227.55M 629K Sep/2026
STAAR Surgical USD 14.36M 5.64M Sep/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Waters USD 554M 158M Sep/2026